MAYNE PHARMA GROUP LTD (MAYNF:OTCMKTS)
$1.6 0.2 (14.2857%)
Analysed MAYNE PHARMA GROUP LTD (MAYNF:OTCMKTS) News Sources
Sol-Gel Reports Second Quarter 2025 Financial Results and Provides Corporate Updates
15-08-2025
yahoo.com
ASX Penny Stocks To Watch In September 2025
18-09-2025
yahoo.com
[Latest] Global Aspirin Market Size/Share Worth USD 3.40 Billion by 2034 at a 3.1% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth Rate, Value, SWOT Analysis)
21-10-2025
yahoo.com
3 ASX Penny Stocks With Market Caps Under A$400M
09-11-2025
yahoo.com
Australia blocks Cosette’s takeover of Mayne Pharma
21-11-2025
investmentmonitor.ai
Termination of Proposed Acquisition of Mayne Pharma
11-12-2025
yahoo.com
ASX Penny Stocks To Watch With Market Caps Over A$100M
10-02-2026
yahoo.com
Mayne Pharma Group Ltd (MAYNF) (H1 2026) Earnings Call Highlights: Strategic Growth Amidst ...
23-02-2026
yahoo.com
Mayne Pharma growth strategy in Women’s health - ASX SMIDcaps Conference
25-03-2026
yahoo.com
3 ASX Penny Stocks With Market Caps Over A$70M To Consider
22-05-2026
yahoo.com
What is the current price of MAYNE PHARMA GROUP LTD (MAYNF:OTCMKTS)?
The current price of MAYNE PHARMA GROUP LTD (MAYNF:OTCMKTS) is $1.6.
MAYNE PHARMA GROUP LTD (MAYNF:OTCMKTS) absolute price change since previous trading day?
The absolute price change of MAYNE PHARMA GROUP LTD (MAYNF:OTCMKTS) since the previous trading day is $0.2.
MAYNE PHARMA GROUP LTD (MAYNF:OTCMKTS) percentage price change since previous trading day?
The percentage price change of MAYNE PHARMA GROUP LTD (MAYNF:OTCMKTS) since the previous trading day is 14.2857%.
What is the most recent average sentiment score for MAYNE PHARMA GROUP LTD (MAYNF:OTCMKTS)?
The most recent average sentiment score for MAYNE PHARMA GROUP LTD (MAYNF:OTCMKTS) is 70 out of 100.
What is the most recent average sentiment for MAYNE PHARMA GROUP LTD (MAYNF:OTCMKTS)?
The most recent sentiment for MAYNE PHARMA GROUP LTD (MAYNF:OTCMKTS) is .
SEC-8K** Filing Available For MAYNE PHARMA GROUP LTD (MAYNF:OTCMKTS)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.